Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bsuedu.ru/handle/123456789/66353
Title: The excretion study of 4-(5-methyl-1,3,4-oxadiazole-2-yl)-benzenesulfonamide in rats
Authors: Khokhlov, A. L.
Yaichkov, I. I.
Shetnev, A. A.
Korsakov, M. K.
Volkhin, N. N.
Keywords: medicine
pharmacology
urine
feces
stabilization
validation
pharmacokinetics
excretion
rats
carbonic anhydrase II inhibitor, N-hydroxysulfonamide
Issue Date: 2025
Citation: The excretion study of 4-(5-methyl-1,3,4-oxadiazole-2-yl)-benzenesulfonamide in rats / A.L. Khokhlov, I.I. Yaichkov, A.A. Shetnev [et al.] // Research Results in Pharmacology. - 2025. - Vol.11, №4.-P. 187-198. - Doi: 10.18413/rrpharmacology.11.524. - Refer.: p. 197-198.
Abstract: The 4-(5-methyl-1,3,4-oxadiazole-2-yl)-benzenesulfonamide (ODASA) is a new carbonic anhydrase II inhibitor for open-angle glaucoma treatment, but the excretion study of this compound has not been performed yet. Aim: Calculation of excretion parameters of ODASA and its metabolites in urine and feces in rats
URI: http://dspace.bsuedu.ru/handle/123456789/66353
Appears in Collections:Vol. 11, № 4

Files in This Item:
File Description SizeFormat 
Khokhlov_The excretion_25.pdf828.67 kBAdobe PDFView/Open
Show full item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.